Sagefield Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Sagefield Capital’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,000	Closed	-$598K	–	121
2022 Q4	$598K	Buy	+40,000	New	+$554K	0.15%	76

Sagefield Capital's AVEO Position: Q1 2023 in Review

Sagefield Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 40,000 shares — an estimated $598K sold.

Sagefield Capital first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $598K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Sagefield Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Sagefield Capital sold 40,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $598K.
Sagefield Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Sagefield Capital's AVEO Pharmaceuticals, Inc. position peaked at $598K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Sagefield Capital's 13F filing for Q1 2023, filed 15 May 2023.